NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000056205

Registered date:20/11/2024

Efficacy and Safety of Early Neuromuscular Blocking Agent Therapy in Patients with Moderate to Severe ARDS: A Systematic Review

Basic Information

Recruitment status Pending
Health condition(s) or Problem(s) studiedAcute Respiratory Distress Syndrome (ARDS)
Date of first enrollment2024/11/19
Target sample size
Countries of recruitmentJapan
Study typeOthers,meta-analysis etc
Intervention(s)

Outcome(s)

Primary OutcomeTo evaluate the efficacy of early neuromuscular blockade in reducing mortality among patients with moderate to severe ARDS, initiated within 48 hours of diagnosis.
Secondary OutcomeTo determine whether the use of neuromuscular blocking agents in patients with moderate or severe ARDS, initiated within 48 hours of diagnosis, improves the quality of life (QOL) as measured by EQ-5D, reduces the incidence of pressure injuries, shortens the duration of mechanical ventilation, and decreases the occurrence of ICU-acquired weakness. A subgroup analysis will compare studies where the control group received deep sedation versus light sedation.

Key inclusion & exclusion criteria

Age minimumNot applicable
Age maximumNot applicable
GenderMale and Female
Include criteria
Exclude criteriaPatients with a history of neuromuscular blocking agent use within the past 2 weeks. Patients with chronic respiratory failure.

Related Information

Contact

public contact
Name Kenzo Ishii
Address 5-23-1 Zao-cho, Fukuyama, Hiroshima, Japan Japan 721-8511
Telephone 0849415151
E-mail keishii1101@gmail.com
Affiliation Fukuyama City Hospital Department of Anesthesiology, Intensive Care Unit
scientific contact
Name Kenzo Ishii
Address 5-23-1 Zao-cho, Fukuyama, Hiroshima, Japan Japan
Telephone 084-951-5151
E-mail keishii1101@gmail.com
Affiliation Fukuyama City Hospital Department of Anesthesiology, Intensive Care Unit